Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorKessler Foundation
About this trial
The purpose of this research study is to evaluate the usefulness of a wearable robotic exoskeleton device (Ekso-GT), to improve learning and memory, and gait therapy in persons with walking disability due to Multiple Sclerosis. The study will evaluate the mobility, learning and memory, and walking abilities of individuals with multiple sclerosis who went through the traditional as compared to others who used the robotic exoskeleton as part of their therapy.
Eligibility criteria
Qualifiers
Be diagnosed with multiple sclerosis.
Be determined by the study staff to have moderate to severe difficulty walking but still be able to walk while using the robotic exoskeleton.
Have some difficulty thinking and problem solving as determined by my performance on a special test that I will take during the screening visit.
Be between the ages of 18 and 75.
Disqualifiers
Have a history of head injury, stroke, seizures, or any other significant neurological history other than MS.
Have a high degree of difficulty in thinking and problem solving that prevents me from participating in the study as determined by my performance on a special test taken during the screening visit.
Be currently taking steroids, benzodiazepines, antipsychotics, and/or neuroleptics as determined by study staff review of my medications.
Be pregnant.
Trial design
Treatments tested in this trial
- Robotic Exoskeleton Rehabilitation
- Conventional Gait Therapy
Treatment groups
10 Participants
are divided into 2 treatment groupsSponsors and collaborators
Kessler Foundation
Lead sponsor
Kessler Institute for Rehabilitation
Collaborator
Source ClinicalTrials.gov